Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  MELITAC 12.1 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
INCB024360 and Vaccine Therapy in Treating Patients with Stage III-IV Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-04, NCI-2013-01605, NCT01961115
Start Over